Teresa Siegert

Friedrich-Alexander-Universität Erlangen-Nürnberg

Papers

1

Total Citations

5

H-Index

1

About

Dr. Teresa Siegert is a leading figure in pharmaceutical engineering, whose work is redefining quality control for freeze-dried pharmaceuticals. Her research centers on the critical intersection of process analytical technology and structural characterization, specifically addressing the challenges of lyophilization. Dr. Siegert’s major contribution is the development of automated, non-destructive tomographic methods to assess structural defects in lyophilisates. Her seminal 2024 paper, which has garnered early attention with 5 citations, demonstrates how topology and surface characteristics directly impact drug stability and reconstitutability. By replacing slow, labor-intensive visual inspections with rapid, automated imaging, her work promises to accelerate production and enhance product safety. This innovation is particularly vital for biologics and vaccines, where structural integrity is paramount. Dr. Siegert’s research is not only advancing fundamental understanding of freeze-drying dynamics but also providing the pharmaceutical industry with a powerful tool for real-time quality assurance, marking her as a rising innovator in drug manufacturing technology.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Automated Tomographic Assessment of Structural Defects of Freeze-Dried Pharmaceuticals
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago